Archive for Friday, December 15, 2006

Medication uses CyDex technology

December 15, 2006


A drug-delivery compound with origins at Kansas University now is being used in medicine for treating schizophrenia and bipolar disorder.

CyDex Inc., a Lenexa-based pharmaceuticals company, announced Thursday that Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. Ltd. were using CyDex's Captisol technology - technology invented at KU's Higuchi Biosciences Center - in an injection formulation of Abilify, an antipsychotic medication.

The U.S. Food and Drug Administration approved the Abilify injection Sept. 20.


Use the comment form below to begin a discussion about this content.

Commenting has been disabled for this item.